DOI: 10.1055/s-00023610

Drug Research

Referenz

Karp JE, Lancet JE.
Tipifarnib in the treatment of newly diagnosed acute myelogenous leukemia.

Biologics: targets & therapy 2008;
2: 491-500 https://doi.org/10.2147/btt.s3485

Bibliographische Angaben herunterladen

Suchen in: